From blue jeans to blue genes.
Cutaneous venous anomalies are common. They are blue and vary in size, number, and location and account for most consultations at specialized interdisciplinary clinics for vascular anomalies. Venous lesions are clinically important because they cause pain, dysfunction, destruction of adjacent tissues, and esthetic concern. Only resection and sclerotherapy are helpful, although not always curative. Understanding etiopathogenesis could help design animal models and develop novel therapeutic approaches. John B. Mulliken, MD, envisioned a project to uncover the genetic basis of an inherited form of venous malformation in a large New England family. Recruitment of 2 young fellows resulted in a collaborative project that unraveled the searched-for gene and its mutation. This was an opening for a new era in vascular anomalies. Two blue genes' mutations were discovered, which account for most, if not all, of the inherited forms of venous anomalies, but other genes as well, for rheologically diverse lesions. Differential diagnosis and management has improved, and animal models are being made. This was achieved through the help of Dr Mulliken, who inspired 2 young investigators in blue jeans to find 2 blue genes.
Boon
Laurence M
LM
Center for Vascular Anomalies, Division of Plastic Surgery, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Vikkula
Miikka
M
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D000818:Animals; D004195:Disease Models, Animal; D018095:Germ-Line Mutation; D005918:Glomus Tumor / Q000235:genetics*; D006801:Humans; D042787:Receptor, TIE-2 / Q000235:genetics; D012867:Skin / Q000098:blood supply; D012878:Skin Neoplasms / Q000235:genetics*; D054079:Vascular Malformations / Q000235:genetics*; D014680:Veins / Q000002:abnormalities
D048868:Adaptor Proteins, Signal Transducing; C103024:GLMN protein, human; D042787:Receptor, TIE-2